John P. Schmid
Director at Anaptysbio, Inc (ANAB); Director at BlossomHill Therapeutics, Inc. (BLSM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$9K
Total bought / sold$96K / $1.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 10SEC | BLSMBlossomHill Therapeutics, Inc. | Buy | 6,000new position | $16.00 | $96K | +9.3% |
| Apr 1SEC | ANABAnaptysbio, Inc | Sell | 12,59639,671 held (−24%) | $55.71 | $702K | -17.5% |
| Apr 1SEC | ANABAnaptysbio, Inc | Sell | 7,52732,144 held (−19%) | $56.70 | $427K | -19.0% |
| Apr 1SEC | ANABAnaptysbio, Inc | Sell | 52231,622 held (−2%) | $57.40 | $30K | -19.9% |
- Buy
Director John P. Schmid bought $96K of BLSM at $16.00 — first open-market purchase in our records; opens a new position.